The Enterprise Value as of June 2026 (TTM) for Metagenomi, Inc. Common Stock (MGX) is 59.06M

According to Metagenomi, Inc. Common Stock’s latest financial reports and current stock price. The company's current Enterprise Value is 59.06M. This represents a change of -19.28% compared to the average of 73.16M of the last 4 quarters.

Metagenomi, Inc. Common Stock (MGX) Historical Enterprise Value (quarterly & annually)

How has MGX Enterprise Value performed in the past?

The mean historical Enterprise Value of Metagenomi, Inc. Common Stock over the last ten years is 159.59M. The current 59.06M Enterprise Value has changed 3.60% with respect to the historical average. Over the past ten years (40 quarters), MGX's Enterprise Value was at its highest in in the June 2023 quarter at 383.11M. The Enterprise Value was at its lowest in in the June 2022 quarter at 0.

Metagenomi, Inc. Common Stock (MGX) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Metagenomi, Inc. Common Stock Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Metagenomi, Inc. Common Stock (MGX) Average Enterprise Value

How has MGX Enterprise Value performed in the past?

The current Enterprise Value of Metagenomi, Inc. Common Stock (MGX) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Metagenomi, Inc. Common Stock (MGX) Enterprise Value vs. Peers

How is MGX’s Enterprise Value compared to its peers?

Metagenomi, Inc. Common Stock’s Enterprise Value is greater than Precision BioSciences, Inc. (7.35M), greater than aTyr Pharma, Inc. (44.87M), less than Adverum Biotechnologies, Inc. (159.14M), less than Artiva Biotherapeutics, Inc. (200.39M), less than Sutro Biopharma, Inc. (218.65M), greater than Quince Therapeutics, Inc. (-12558018.00), less than InflaRx N.V. (85.69M), greater than Kalaris Therapeutics Inc (47.97M), less than Connect Biopharma Holdings Limited (95.83M), less than ALX Oncology Holdings Inc. (185.54M),

Build a custom stock screener for Metagenomi, Inc. Common Stock (MGX) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Metagenomi, Inc. Common Stock using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Metagenomi, Inc. Common Stock (MGX) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Metagenomi, Inc. Common Stock or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.